clinical trials summit: Live & Latest News Updates : Vimarsana.com

Vial to Sponsor the 21st Precision in Clinical Trials Summit 2023 in San Diego, CA

Trust key to improving Black patient representation in lupus trials

Sonar Clinical Research Diversity in Clinical Trials Summit Signifies a Significant Achievement in Promoting Healthcare Equity Within the Community

The Diversity in Clinical Trials Summit, held on April 22nd 2023, at The Gathering Spot, Atlanta Ga proved to be an extraordinary community event focused on...

Antibe's Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit

Antibe Therapeutics Inc. , a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies to target inflammation, today announced its participation in... | April 25, 2023

Scramble for specialty syringes as Pfizer, feds look to extract 6th vaccine doses

Jan 28, 2021 10:36am Pfizer and BioNTech's COVID-19 vaccine vials contain an extra doses of the in-demand shot, but those doses can only be accessed with a special needle.(Kunal Mahto/iStock/Getty Images Plus/Getty Images) Syringe makers are scrambling to meet demand for so-called low dead space syringes as Pfizer and the U.S. look to squeeze out extra vaccine doses. The specialty needles are needed to eke out a sixth shot in Pfizer and BioNTech's Comirnaty prepared five-dose glass vials. Physicians and pharmacists discovered the potential extra dose after they began vaccinating patients. But initial enthusiasm has been dampened by the requirement of the now-scarce specialty needles to extract the last bit from each vial.

Pfizer and Moderna haven't proven their COVID-19 vaccines shield against new variants: analysts

Jan 28, 2021 10:52am One infectious disease specialist said efforts to determine if existing vaccines will work against new COVID strains have left us "in a state of ignorance" due to incomplete data.(Bill Oxford/Getty Images) Just as the U.S. government is starting to ramp up purchases of Pfizer’s and Moderna’s mRNA vaccines to prevent COVID-19, a troubling question is emerging in the scientific community: Can these shots protect people against aggressive new variants racing through the U.K., South Africa and Brazil? Several analysts have scoured the medical literature and interviewed infectious disease experts in an effort to answer that question. Their conclusion? There is no clear answer. At least not yet.

Order up: U.S. calls on Pfizer, Moderna for 200M more vaccine doses

Can Pfizer and Moderna deliver an additional 200 million COVID-19 vaccine doses to the U.S. by this summer? That's what President Joe Biden said he wants the companies to do as the administration works to bulk up vaccine supplies and dramatically speed up nationwide immunizations.

Ultragenyx earns 2 rare disease drug approvals—and a validated commercial strategy

Jan 29, 2021 9:45am Ultragenyx nabbed its third and fourth FDA approvals in 2020 and pushed through the pandemic by reaching out to patients directly. (Ultragenyx) Rare disease pharma companies spend a lot of time looking for patients and investing in keeping them on their meds. But what happens during a pandemic lockdown? At Ultragenyx, patient support teams kicked into high gear, making thousands of proactive outbound calls to find out what patients needed to continue their treatment. It had just nabbed a second approval for FGF23 hormone blocker Crysvita in June 2020 for tumor-induced osteomalacia. The first nod for the drug, developed by Ultragenyx and partner Kyowa Kirin, came in April 2018 for X-linked hypophosphatemia.

Lilly amps Type 1 diabetes partnerships to reach more young people

Jan 28, 2021 10:30am Eli Lilly is expanding its global Type 1 diabetes efforts to provide insulin supplies and education to young people. (Eli Lilly) Eli Lilly is renewing and expanding a longtime Type 1 diabetes partnership to support more than six times as many children in the next 10 years. Working with Life for a Child, Lilly plans to expand care to 150,000 young people with diabetes over the next decade, up from 23,000 last year. The global initiative provides free immediate care with medicine and equipment like reusable pens and monitors, but also longer-term education and support in living with the chronic illness. As part of the new push, Life for a Child is joining with diabetes non-profit and advocacy group Beyond Type 1. That well-known group's four co-founders include Jonas Brothers singer Nick Jonas and "Top Chef" alum Sam Talbot from the Bravo TV series. The group claims to be the largest diabetes online organization with a myriad of efforts that fund everything from political lobbying and education programs to research for cures and assistance with medical supplies.

Roche taps into quantum computing software for Alzheimer's disease research

(Getty Images) Alzheimer’s disease has proven to be stubbornly difficult to unravel, but Roche aims to tap into a new tool that promises to accelerate the process: the quantum computer.  Through a multi-year partnership with the U.K.’s Cambridge Quantum Computing, the Swiss drugmaker’s task force plans to explore the nascent technology’s potential for designing and delivering new therapeutic compounds.  The partnership follows a similar endeavor launched earlier this year between Google and Boehringer Ingelheim, which plans to staff its own quantum laboratory as part of the Big Pharma’s digital transformation. Google has also been developing its own quantum hardware, in the Sycamore processor, which it says has outperformed so-called “classical” supercomputers.